Audentes Therapeutics, Inc., An Astellas Company
http://audentestx.com/We are developing transformative genetic medicines for patients living with serious, rare neuromuscular conditions.
Location: United States, San Francisco
Total raised: $30M
Investors 4
| Date | Name | Website |
| - | Asset Mana... | assetman.c... |
| - | Aisling Ca... | aislingcap... |
| - | 5AM Ventur... | 5amventure... |
| - | Sofinnova ... | sofinnova.... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 13.10.2015 | Series C | $65M | - | Audentes T... |
| 02.12.2014 | Series B | $42.5M | - | Audentes T... |
| 18.07.2013 | Series A | $30M | - | Audentes T... |
Mentions in press and media 9
| Date | Title | Description | Category | Author | Source |
| 28.06.2020 | Two patien... | Two patients in a study of a h... | - | - | statnews.c... |
| 26.08.2016 | Sofinnova ... | The company’s strategy of in... | - | - | medcitynew... |
| 13.10.2015 | Audentes T... | Audentes Therapeutics, Inc., a... | USA | - | finsmes.co... |
| 13.10.2015 | Gene thera... | The round was led by existing ... | - | - | medcitynew... |
| 13.10.2015 | Daily fund... | EverString raised $65M; Audent... | - | Mitos Suso... | vator.tv/n... |
| 04.12.2014 | West Coast... | Share Share on Facebook Share ... | - | Alex Lash | xconomy.co... |
| 02.12.2014 | Audentes T... | Audentes Therapeutics, Inc., a... | USA | - | finsmes.co... |
| 18.10.2013 | Health IT ... | Here were the biggest health I... | - | - | medcitynew... |
| 18.07.2013 | Audentes T... | Audentes Therapeutics, Inc., a... | funding S... | - | finsmes.co... |